Tag: 2.5B

AI drug discovery firm Insilico Medicine signs deal with Korea’s SK Biopharmaceuticals worth $2.5B

Insilico Medicine, the Hong Kong-listed AI drug discovery company, has signed a partnership with Korea’s SK…